@article{article, title  = {{Practical management of the JAK1 inhibitor abrocitinib for atopic dermatitis in clinical practice: special safety considerations}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/215601 }},

 year = {{2024}},

 month = {{7}},

 author = {{Gooderham MJ and de Bruin-Weller M and Weidinger S and Cork MJ and Eichenfield LF and Simpson EL and Tsianakas A and Kerkmann U and Feeney C and Romero W}},

 doi = {{10.1007/s13555-024-01200-5}},

 volume = {{14}},

 journal = {{Dermatology and Therapy}},

 issue = {{8}},

 pages = {{2285-2296,}},

 note = {{Accessed on 2025/11/05}}}